Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell A Psotka

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
JACC. Heart Failure|January 10, 2021
Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid CardiomyopathyMitchell A Psotka
JACC. Heart Failure|December 3, 2021
Quality of Life Always MattersMitchell A Psotka
JACC. Heart Failure|July 27, 2023
Step by Step: Really Need It in Our WorldMitchell A Psotka
Frontiers in Cardiovascular Medicine|February 8, 2024
Rethinking heart failure clinical trials: the heart failure collaboratoryMutaz Alkalbani, Mitchell A Psotka
The American Journal of Managed Care|September 7, 2023
Heart failure without a reduced ejection fractionSant Kumar, Mitchell A Psotka
JACC. Heart Failure|December 14, 2020
Kidney, You Are My FriendMitchell A Psotka, Hector Ventura
European Journal of Heart Failure|July 17, 2015
Cardiac myosin activators: up and comingMitchell A Psotka, John R Teerlink
JACC. Heart Failure|June 11, 2018
Patient-Reported Outcome Instruments in Heart Failure: Are They Preserved?Mitchell A Psotka, John R Teerlink
Journal of General Internal Medicine|December 3, 2014
Aspirin for primary prevention: what's a clinician to do?Mitchell A Psotka, Kirsten E Fleischmann
Current Problems in Cardiology|September 20, 2014
Atrial fibrillation: antiarrhythmic therapyMitchell A Psotka, Byron K Lee
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
JACC. Heart Failure|January 10, 2021
Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid CardiomyopathyMitchell A Psotka
JACC. Heart Failure|December 3, 2021
Quality of Life Always MattersMitchell A Psotka
JACC. Heart Failure|July 27, 2023
Step by Step: Really Need It in Our WorldMitchell A Psotka
Frontiers in Cardiovascular Medicine|February 8, 2024
Rethinking heart failure clinical trials: the heart failure collaboratoryMutaz Alkalbani, Mitchell A Psotka
The American Journal of Managed Care|September 7, 2023
Heart failure without a reduced ejection fractionSant Kumar, Mitchell A Psotka
JACC. Heart Failure|December 14, 2020
Kidney, You Are My FriendMitchell A Psotka, Hector Ventura
European Journal of Heart Failure|July 17, 2015
Cardiac myosin activators: up and comingMitchell A Psotka, John R Teerlink
JACC. Heart Failure|June 11, 2018
Patient-Reported Outcome Instruments in Heart Failure: Are They Preserved?Mitchell A Psotka, John R Teerlink
Journal of General Internal Medicine|December 3, 2014
Aspirin for primary prevention: what's a clinician to do?Mitchell A Psotka, Kirsten E Fleischmann
Current Problems in Cardiology|September 20, 2014
Atrial fibrillation: antiarrhythmic therapyMitchell A Psotka, Byron K Lee
Pageof 10